Centene (CNC) Stock Forecast & Price Target

$62.94 -0.92 (-1.44%)

As of 03:59 PM Eastern

Centene - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
0

Hold
7

Buy
9

Based on 16 Wall Street analysts who have issued ratings for Centene in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 7 have given a hold rating, and 9 have given a buy rating for CNC.

Consensus Price Target

$80.85
28.45% Upside

According to the 16 analysts' twelve-month price targets for Centene, the average price target is $80.85. The highest price target for CNC is $93.00, while the lowest price target for CNC is $64.00. The average price target represents a forecasted upside of 28.45% from the current price of $62.94.

Get the Latest News and Ratings for CNC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Centene and its competitors.

CNC Analyst Ratings Over Time

Type	Current Forecast 4/14/24 to 4/14/25	1 Month Ago 3/15/24 to 3/15/25	3 Months Ago 1/15/24 to 1/14/25	1 Year Ago 4/15/23 to 4/14/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)	6 Buy rating(s)
Hold	7 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$80.85	$79.92	$80.92	$85.08
Forecasted Upside	28.45% Upside	37.17% Upside	27.56% Upside	20.28% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

CNC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Centene Stock vs. The Competition

Type	Centene	Medical Companies	S&P 500
Consensus Rating Score	2.56	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	28.61% Upside	23,601.17% Upside	26.55% Upside
News Sentiment Rating	Positive News See Recent CNC News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/9/2025	Guggenheim 2 of 5 stars	Jason Cassorla Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral
4/8/2025	Jefferies Financial Group 2 of 5 stars	David Windley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Hold	$53.00 ➝ $64.00	+4.45%
2/14/2025	Wells Fargo & Company 3 of 5 stars	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$76.00 ➝ $72.00	+26.47%
2/6/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Staszak Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
2/4/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$66.00 ➝ $71.00	+14.78%
12/17/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Overweight	$80.00 ➝ $75.00	+26.75%
12/13/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$75.00 ➝ $73.00	+22.09%
12/13/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$91.00 ➝ $93.00	+57.71%
12/13/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$89.00 ➝ $84.00	+42.45%
12/13/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$95.00 ➝ $85.00	+46.55%
Get the Latest News and Ratings for CNC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.
12/13/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Caliendo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$79.00 ➝ $80.00	+37.93%
12/11/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$90.00 ➝ $90.00	+63.07%
10/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$96.00 ➝ $88.00	+42.19%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$82.00 ➝ $87.00	+11.80%
7/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $89.00	+14.68%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
9/5/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Neutral	$79.00 ➝ $72.00	+17.51%
8/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$94.00 ➝ $73.00	+13.28%
7/12/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$80.00 ➝ $76.00	+12.91%
4/26/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$94.00 ➝ $87.00	+25.56%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:08 PM ET.

Should I Buy Centene Stock? CNC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, April 7, 2025. Please send any questions or comments about these Centene pros and cons to contact@marketbeat.com.

Centene
Bull Case

Here are some ways that investors could benefit from investing in Centene Co.:

Centene Co. recently reported earnings per share (EPS) of $0.80, significantly exceeding analysts' expectations of $0.49, indicating strong financial performance and effective management.
The company has a market capitalization of $30.82 billion, which reflects its substantial size and stability in the healthcare sector, making it a potentially safer investment.
With a current stock price of $62.13, Centene Co. is trading below several analysts' price targets, suggesting potential for price appreciation as the market corrects.
Analysts have given Centene Co. a consensus rating of "Moderate Buy," with ten analysts recommending buying the stock, which indicates positive sentiment among market experts.
The company has shown a revenue increase of 3.4% compared to the same quarter last year, demonstrating growth and resilience in its business operations.

Centene
Bear Case

Investors should be bearish about investing in Centene Co. for these reasons:

Jefferies Financial Group recently downgraded Centene Co. from a "hold" to an "underperform" rating, which may signal concerns about the company's future performance.
One analyst has issued a sell rating on the stock, indicating that there are significant concerns about its valuation and future prospects.
The stock has a relatively low price-to-earnings (P/E) ratio of 9.96, which could suggest that the market has low expectations for future growth compared to its peers.
Centene Co. has a debt-to-equity ratio of 0.70, which, while manageable, indicates that the company is using a moderate amount of debt to finance its operations, potentially increasing financial risk.
Recent price target adjustments by analysts, including a reduction from $95.00 to $85.00 by Oppenheimer, may reflect a lack of confidence in the stock's short-term performance.

CNC Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Centene is $80.85, with a high forecast of $93.00 and a low forecast of $64.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 7 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNC shares.
: According to analysts, Centene's stock has a predicted upside of 28.45% based on their 12-month stock forecasts.
: Over the previous 90 days, Centene's stock had 1 upgrade and 1 downgrade by analysts.
: Centene has been rated by research analysts at Argus, Guggenheim, Jefferies Financial Group, Robert W. Baird, and Wells Fargo & Company in the past 90 days.
: Analysts like Centene less than other "medical" companies. The consensus rating score for Centene is 2.56 while the average consensus rating score for "medical" companies is 2.82. Learn more on how CNC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CNC) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Stock Forecast & Price Target